Notably, the absence of significant changes in ETC complex activities (Fig. 3K; Fig. S2) underscores that Spn-H2O2 targets upstream TCA cycle enzymes rather than the ETC itself, a mechanism distinct from the ETC decline associated with human diseases like neurodegeneration, cancer, and diabetes (54). The gene discussed is SPN; the disease is cancer.